Contents

Current Drug Targets, Volume 14 - Number 7

Editorial (Hot Topic: The First Theme Issue on PPARs for Brain Disorders)

, 14(7): 723

Regis Bordet and Benjamin Rolland


DOI: 10.2174/1389450111314070001




Therapeutic Prospects of PPARs in Psychiatric Disorders: A Comprehensive Review

, 14(7): 724 - 732

Benjamin Rolland, Julie Deguil, Renaud Jardri, Olivier Cottencin, Pierre Thomas and Regis Bordet


DOI: 10.2174/1389450111314070002




Targeting PPAR Isoforms Following CNS Injury

, 14(7): 733 - 742

Heather M. Yonutas and Patrick G. Sullivan


DOI: 10.2174/1389450111314070003




PPAR-γ: Therapeutic Prospects in Parkinson's Disease

, 14(7): 743 - 751

Anna R. Carta


DOI: 10.2174/1389450111314070004




PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke

, 14(7): 752 - 767

Thavarak Ouk, Camille Potey, Sophie Gautier, Michele Bastide, Dominique Deplanque, Bart Staels, Patrick Duriez, Didier Leys and Regis Bordet


DOI: 10.2174/1389450111314070005




Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence

, 14(7): 768 - 776

Bernard Le Foll, Patricia Di Ciano, Leigh V. Panlilio, Steven R. Goldberg and Roberto Ciccocioppo


DOI: 10.2174/1389450111314070006




Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis

, 14(7): 777 - 797

Umang Swami, Sanjay Goel and Sridhar Mani


DOI: 10.2174/1389450111314070007




Cyclization in Opioid Peptides

, 14(7): 798 - 816

Justyna Piekielna, Renata Perlikowska, Katarzyna Gach and Anna Janecka


DOI: 10.2174/1389450111314070008




Progress in Structure-Based Design of EGFR Inhibitors

, 14(7): 817 - 829

Petar M. Mitrasinovic


DOI: 10.2174/1389450111314070009




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science